PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4700
+0.0100 (2.17%)
At close: Jan 9, 2026
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 78.46 million as of January 9, 2026. Its market cap has increased by 7.88% in one year.
Market Cap
78.46M
Enterprise Value
77.98M
Revenue
17.60M
Ranking
n/a
PE Ratio
291.02
Stock Price
0.47
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 78.46M, an increase of 3,168.98%. That is a compound annual growth rate of 189.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 78.46M | 3.30% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.74B |
| Green Thumb Industries | 2.64B |
| dentalcorp Holdings | 2.19B |
| Extendicare | 2.08B |
| Trulieve Cannabis | 2.04B |
| Sienna Senior Living | 2.01B |
| Cronos Group | 1.41B |
| WELL Health Technologies | 1.04B |